AngioDynamics, Inc. (ANGO) - Year-over-year earnings per share growth for the last twelve months

Brandmark of AngioDynamics Corp (ANGO)

Steady clinic demand for vascular therapy provides AngioDynamics, Inc. (ANGO) with predictable cash flows. The quarterly EPS variation on this GURU.Markets chart illustrates profit dynamics, where 36.30 reflects the latest metric value. Cost optimization is achieved through the robotization of casting lines, while business resilience is bolstered by the neutral status of the biomedical sector amid global geopolitical fractures.

ANGO: AngioDynamics Year-over-year earnings per share growth rate for the last twelve months 07/04/2022 - 11/13/2026
Finished products of AngioDynamics, Inc.

Investors must find a balance between asset quality and the business's market value. This metric measures the dynamics of earnings per share, reflecting the efficiency of capital generation. For AngioDynamics, Inc. (ANGO), this growth confirms the commercial success of integrating innovative catheters and thromboextraction systems into surgical practice. Analyzing the quarterly EPS growth vector allows for the timely detection of overvaluation or stagnation.

Analysis of competing companies

Intuitive (ISRG) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months DHR|Year-over-year earnings per share growth for the last twelve months Becton, Dickinson and Company|STERIS Group (STE) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months WST (West Pharmaceutical Services)|Year-over-year earnings per share growth rate for the last twelve months BAX|Year-over-year earnings per share growth for the last twelve months Masimo MASI|Year-over-year earnings per one share growth for the last 12 months STVN|TFX: Year-over-year net earnings per share growth for the last 12 months|MMSI - Quarterly EPS earnings growth|Envista Holdings (NVST) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months icumed.com|XRAY (Dentsply Sirona) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months LeMaitre Vascular Inc LMAT|Year-over-year earnings per share growth for the last twelve months AtriCure Corp (ATRC)|STAAR Surgical Co - Year-over-year earnings per share growth for the last 12 months|Chromadex Corp - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ZIMV (zimvie.com)|CERS - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Alpha Teknova TKNO|MGRM: Quarterly EPS earnings growth|Sharps Technology (STSS) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months InfuSystem|Year-over-year earnings per share growth for the last 12 months UTMD (utahmed.com)|Quarterly EPS earnings growth KRMD|Nyxoah SA (NYXH) - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth MBOT (Microbot Medical Inc)|Year-over-year net earnings per share change for the last twelve months Pro-Dex Inc. (PDEX)|ZTEK - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months elutia.com|MLSS: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months NXGL|Year-over-year net earnings per share growth for the last 12 months RVP|Earnings per share growth in annualized terms for the last twelve months Harvard Bioscience Inc. HBIO|Year-over-year earnings per share growth for the last twelve months Femasys Inc. (FEMY)|meihuamed.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth POAI (Predictive Oncology Inc.)|Quarterly EPS earnings growth Callan JMB Inc. CJMB|ATRI - Year-over-year earnings per share growth for the last twelve months|NeuroMetrix Corporation (NURO) - Year-over-year net earnings per share growth for the last 12 months